Telemedicine-friendly devices best tools for glaucoma screening

Article

Cup-to-disc ratios and visual field evaluations using telemedicine-friendly devices are the most useful tools for glaucoma screening.

Cup-to-disc ratios and visual field evaluations using telemedicine-friendly devices are the most useful tools for glaucoma screening, according to a report in the April issue of Clinical & Experimental Ophthalmology.

Sajeesh Kumar and co-workers from the University of Western Australia, Australia screened 399 eyes with telemedicine-friendly devices and conventional, hospital based devices such as ophthalmoscopes, tonometers and perimeters.

The combination of age and family history of glaucoma alone has a sensitivity of 35.6% (specificity 94.2%, area under the curve 0.81, correctly classified 81.1%) and the addition of telemedicine-friendly or conventional visual field tests increased the sensitivity to 91.1% (specificity 93.6%, area under the curve 0.95, correctly classified 93%).

Analysis indicated a good level of agreement between vertical cup-to-disc ratio by ophthalmoscopy and digital image reading. The addition of an intraocular pressure test did not alter sensitivity (35.6%) or specificity (94.2%).

The results of this study indicate that telemedicine-friendly devices are the most useful tools for glaucoma screening.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.